| Aktie | Ticker | Breite | GCS | 2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 460.970.513 $ | +58.444.286 $ | +27,3 % | 40 | 423.489.426 $ | +247.231 $ | -9,9 % | 42 | 438.714.301 $ | +77.181.238 $ | +25,9 % | 36 | 403.318.033 $ | +108.147.156 $ | +27,3 % | 41 | ||||
| BRISTOL MYERS SQUIBB CO | BMY | → 0 | Neutral | 41.838.746 $ | -8.373.450 $ | -16,7 % | 1 | 50.212.196 $ | +9.975.383 $ | +24,8 % | 1 | 40.236.813 $ | +14.021.671 $ | +53,5 % | 1 | 26.215.142 $ | +7.421.402 $ | +39,5 % | 1 |
| Merck & Co., Inc. | MRK | → 0 | Stark | 27.885.528 $ | -3.430.771 $ | -11,0 % | 1 | 31.316.299 $ | -6.961.605 $ | -18,2 % | 1 | 38.277.904 $ | +11.210.479 $ | +41,4 % | 1 | 27.067.425 $ | +11.077.105 $ | +69,3 % | 1 |
| PFIZER INC | PFE | → 0 | Neutral | 24.181.497 $ | -6.464.594 $ | -21,1 % | 1 | 30.646.091 $ | +9.243.570 $ | +43,2 % | 1 | 21.402.521 $ | -10.500.630 $ | -32,9 % | 1 | 31.903.151 $ | +9.602.351 $ | +43,1 % | 1 |
| Medtronic plc | MDT | → 0 | Neutral | 27.571.147 $ | +3.250.052 $ | +13,4 % | 1 | 24.321.095 $ | -1.580.908 $ | -6,1 % | 1 | 25.902.003 $ | -2.997.718 $ | -10,4 % | 1 | 28.899.721 $ | +9.373.641 $ | +48,0 % | 1 |
| BECTON DICKINSON & CO | BDX | → 0 | Neutral | 14.099.113 $ | +1.109.557 $ | +8,5 % | 1 | 12.989.556 $ | -12.700.654 $ | -49,4 % | 1 | 25.690.210 $ | +5.320.686 $ | +26,1 % | 1 | 20.369.524 $ | +3.489.024 $ | +20,7 % | 1 |
| GILEAD SCIENCES, INC. | GILD | → 0 | Sehr stark | 7.421.034 $ | -14.232.020 $ | -65,7 % | 1 | 21.653.054 $ | +5.309.525 $ | +32,5 % | 1 | 16.343.529 $ | +2.263.039 $ | +16,1 % | 1 | ||||
| INCYTE CORP | INCY | → 0 | Neutral | 19.356.560 $ | +484.559 $ | +2,6 % | 1 | 18.872.001 $ | -2.737.196 $ | -12,7 % | 1 | 21.609.197 $ | +4.213.479 $ | +24,2 % | 1 | 17.395.718 $ | +3.503.318 $ | +25,2 % | 1 |
| AMGEN INC | AMGN | → 0 | Neutral | 9.516.876 $ | -7.074.611 $ | -42,6 % | 1 | 16.591.487 $ | -3.360.021 $ | -16,8 % | 1 | 19.951.508 $ | +2.608.625 $ | +15,0 % | 1 | 17.342.883 $ | +5.057.643 $ | +41,2 % | 1 |
| IONIS PHARMACEUTICALS INC | IONS | → 0 | Schwach | 15.022.918 $ | +2.297.566 $ | +18,1 % | 1 | 12.725.352 $ | -1.908.178 $ | -13,0 % | 1 | 14.633.530 $ | -3.092.869 $ | -17,4 % | 1 | 17.726.399 $ | +6.432.782 $ | +57,0 % | 1 |
| Elevance Health, Inc. | ELV | → 0 | Neutral | 17.209.098 $ | +4.339.222 $ | +33,7 % | 1 | 12.869.876 $ | +1.460.876 $ | +12,8 % | 1 | 11.409.000 $ | +8.306.079 $ | +267,7 % | 1 | 3.102.921 $ | -4.201.359 $ | -57,5 % | 1 |
| BIOMARIN PHARMACEUTICAL INC | BMRN | → 0 | Neutral | 16.875.208 $ | +3.322.240 $ | +24,5 % | 1 | 13.552.968 $ | +1.755.816 $ | +14,9 % | 1 | 11.797.152 $ | +2.273.008 $ | +23,9 % | 1 | 9.524.144 $ | +2.798.674 $ | +41,6 % | 1 |
| THERMO FISHER SCIENTIFIC INC. | TMO | → 0 | Neutral | 16.837.674 $ | +4.270.562 $ | +34,0 % | 1 | 12.567.112 $ | +3.621.403 $ | +40,5 % | 1 | 8.945.709 $ | -1.393.521 $ | -13,5 % | 1 | ||||
| BIOGEN INC. | BIIB | → 0 | Stark | 11.702.458 $ | -4.814.842 $ | -29,2 % | 1 | 16.517.300 $ | +1.474.555 $ | +9,8 % | 1 | 15.042.745 $ | +4.470.207 $ | +42,3 % | 1 | 10.572.538 $ | +4.212.786 $ | +66,2 % | 1 |
| CVS HEALTH Corp | CVS | → 0 | Stark | 16.069.613 $ | +6.349.710 $ | +65,3 % | 1 | 9.719.903 $ | -4.374.354 $ | -31,0 % | 1 | 14.094.257 $ | +2.318.188 $ | +19,7 % | 1 | 11.776.069 $ | +532.329 $ | +4,7 % | 1 |
| IQVIA HOLDINGS INC. | IQV | → 0 | Stark | 15.060.340 $ | +8.199.516 $ | +119,5 % | 1 | 6.860.824 $ | +6.860.824 $ | 1 | |||||||||
| ZIMMER BIOMET HOLDINGS, INC. | ZBH | → 0 | Neutral | 12.251.210 $ | -1.839.391 $ | -13,1 % | 1 | 14.090.601 $ | +2.178.179 $ | +18,3 % | 1 | 11.912.422 $ | +734.839 $ | +6,6 % | 1 | 11.177.583 $ | +3.093.549 $ | +38,3 % | 1 |
| ABBOTT LABORATORIES | ABT | → 0 | Neutral | 13.379.069 $ | +4.392.159 $ | +48,9 % | 1 | 8.986.910 $ | +8.986.910 $ | 1 | |||||||||
| GE HealthCare Technologies Inc. | GEHC | → 0 | Neutral | 13.305.311 $ | +4.306.878 $ | +47,9 % | 1 | 8.998.433 $ | -383.835 $ | -4,1 % | 1 | 9.382.268 $ | +1.016.879 $ | +12,2 % | 1 | 8.365.389 $ | +2.884.209 $ | +52,6 % | 1 |
| CARDINAL HEALTH INC | CAH | → 0 | Stark | 9.666.079 $ | -1.934.206 $ | -16,7 % | 1 | 11.600.285 $ | -1.129.618 $ | -8,9 % | 1 | 12.729.903 $ | +3.385.132 $ | +36,2 % | 1 | 9.344.771 $ | -1.743.229 $ | -15,7 % | 1 |
| BRUKER CORP | BRKR | → 0 | Neutral | 9.168.543 $ | -6.298 $ | -0,1 % | 1 | 9.174.841 $ | -2.823.935 $ | -23,5 % | 1 | 11.998.776 $ | +3.846.743 $ | +47,2 % | 1 | 8.152.033 $ | +78.069 $ | +1,0 % | 1 |
| QIAGEN N.V. | QGEN | → 0 | 11.246.724 $ | +4.745.389 $ | +73,0 % | 1 | 6.501.335 $ | +878.315 $ | +15,6 % | 1 | |||||||||
| CENTENE CORP | CNC | → 0 | Neutral | 10.424.777 $ | +5.107.637 $ | +96,1 % | 1 | 5.317.140 $ | -5.304.045 $ | -49,9 % | 1 | 10.621.185 $ | +3.013.852 $ | +39,6 % | 1 | 7.607.333 $ | -643.227 $ | -7,8 % | 1 |
| UNITEDHEALTH GROUP INC | UNH | → 0 | Neutral | 9.858.947 $ | +9.858.947 $ | 1 | |||||||||||||
| REGENERON PHARMACEUTICALS, INC. | REGN | → 0 | Neutral | 9.839.461 $ | +4.309.012 $ | +77,9 % | 1 | 5.530.449 $ | +5.530.449 $ | 1 | |||||||||
| BIO-RAD LABORATORIES, INC. | BIO | → 0 | Neutral | 9.791.894 $ | +3.171.581 $ | +47,9 % | 1 | 6.620.313 $ | -575.700 $ | -8,0 % | 1 | 7.196.013 $ | +795.550 $ | +12,4 % | 1 | 6.400.463 $ | +2.097.969 $ | +48,8 % | 1 |
| Avantor, Inc. | AVTR | → 0 | Neutral | 8.970.271 $ | +3.518.311 $ | +64,5 % | 1 | 5.451.960 $ | -2.517.358 $ | -31,6 % | 1 | 7.969.318 $ | +2.015.060 $ | +33,8 % | 1 | 5.954.258 $ | +938.551 $ | +18,7 % | 1 |
| BAXTER INTERNATIONAL INC | BAX | → 0 | Stark | 8.687.916 $ | +572.664 $ | +7,1 % | 1 | ||||||||||||
| Edwards Lifesciences Corp | EW | → 0 | Neutral | 5.463.965 $ | +626.973 $ | +13,0 % | 1 | 4.836.992 $ | -3.381.279 $ | -41,1 % | 1 | 8.218.271 $ | +2.542.616 $ | +44,8 % | 1 | 5.675.655 $ | +2.390.835 $ | +72,8 % | 1 |
| PTC THERAPEUTICS, INC. | PTCT | → 0 | Neutral | 8.157.000 $ | +3.047.250 $ | +59,6 % | 1 | 5.109.750 $ | +406.079 $ | +8,6 % | 1 | 4.703.671 $ | -2.544.862 $ | -35,1 % | 1 | 7.248.533 $ | +2.743.043 $ | +60,9 % | 1 |
| LABCORP HOLDINGS INC. | LH | → 0 | Schwach | 7.285.320 $ | +2.210.861 $ | +43,6 % | 1 | 5.074.459 $ | -1.704.068 $ | -25,1 % | 1 | 6.778.527 $ | -676.421 $ | -9,1 % | 1 | 7.454.948 $ | +2.340.203 $ | +45,8 % | 1 |
| Lantheus Holdings, Inc. | LNTH | → 0 | Neutral | 7.080.142 $ | +836.221 $ | +13,4 % | 1 | 6.243.921 $ | +2.940.691 $ | +89,0 % | 1 | 3.303.230 $ | -814.410 $ | -19,8 % | 1 | ||||
| DEXCOM INC | DXCM | → 0 | Neutral | 6.877.917 $ | +3.353.455 $ | +95,1 % | 1 | 3.524.462 $ | -1.527.755 $ | -30,2 % | 1 | 5.052.217 $ | -117.068 $ | -2,3 % | 1 | 5.169.285 $ | +804.785 $ | +18,4 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Schwach | 5.284.415 $ | -1.396.709 $ | -20,9 % | 1 | 6.681.124 $ | +1.385.301 $ | +26,2 % | 1 | 5.295.823 $ | +2.052.450 $ | +63,3 % | 1 | 3.243.373 $ | +3.243.373 $ | 1 | |
| Viatris Inc | VTRS | → 0 | Neutral | 6.621.625 $ | +6.621.625 $ | 1 | |||||||||||||
| HUMANA INC | HUM | → 0 | Neutral | 3.329.435 $ | -2.899.555 $ | -46,5 % | 1 | 6.228.990 $ | +483.710 $ | +8,4 % | 1 | ||||||||
| Elanco Animal Health Inc | ELAN | → 0 | Stark | 6.188.438 $ | +2.017.636 $ | +48,4 % | 1 | ||||||||||||
| TANDEM DIABETES CARE INC | TNDM | → 0 | Sehr schwach | 4.030.403 $ | -1.089.731 $ | -21,3 % | 1 | 5.120.134 $ | -750.526 $ | -12,8 % | 1 | 5.870.660 $ | +2.598.420 $ | +79,4 % | 1 | 3.272.240 $ | -651.909 $ | -16,6 % | 1 |
| Organon & Co. | OGN | → 0 | Sehr stark | 3.666.375 $ | +1.414.291 $ | +62,8 % | 1 | 2.252.084 $ | +101.084 $ | +4,7 % | 1 | 2.151.000 $ | -3.655.833 $ | -63,0 % | 1 | 5.806.833 $ | +5.806.833 $ | 1 | |
| Ascendis Pharma A/S | ASND | → 0 | 5.682.470 $ | +809.377 $ | +16,6 % | 1 | 4.873.093 $ | +1.396.215 $ | +40,2 % | 1 | 3.476.878 $ | -1.359.573 $ | -28,1 % | 1 | 4.836.451 $ | +1.902.251 $ | +64,8 % | 1 | |
| Crinetics Pharmaceuticals, Inc. | CRNX | → 0 | Schwach | 4.289.380 $ | +868.218 $ | +25,4 % | 1 | 3.421.162 $ | -1.932.088 $ | -36,1 % | 1 | 5.353.250 $ | +5.353.250 $ | 1 | |||||
| BOSTON SCIENTIFIC CORP | BSX | → 0 | Neutral | 5.169.743 $ | +5.169.743 $ | 1 | |||||||||||||
| HCA Healthcare, Inc. | HCA | → 0 | Stark | 5.034.618 $ | +396.283 $ | +8,5 % | 1 | 4.638.335 $ | +1.573.535 $ | +51,3 % | 1 | ||||||||
| Kura Oncology, Inc. | KURA | → 0 | Neutral | 4.750.142 $ | +1.402.127 $ | +41,9 % | 1 | 3.348.015 $ | -1.388.173 $ | -29,3 % | 1 | 4.736.188 $ | +856.215 $ | +22,1 % | 1 | 3.879.973 $ | +3.879.973 $ | 1 | |
| Travere Therapeutics, Inc. | TVTX | → 0 | Neutral | 4.544.800 $ | +4.544.800 $ | 1 | |||||||||||||
| ICON PLC | ICLR | → 0 | Neutral | 4.369.225 $ | +4.369.225 $ | 1 | |||||||||||||
| Solventum Corp | SOLV | → 0 | Neutral | 4.325.907 $ | +1.443.987 $ | +50,1 % | 1 | ||||||||||||
| IOVANCE BIOTHERAPEUTICS, INC. | IOVA | → 0 | Schwach | 4.028.819 $ | +869.819 $ | +27,5 % | 1 | 3.159.000 $ | +3.159.000 $ | 1 | |||||||||
| CYTOKINETICS INC | CYTK | → 0 | Neutral | 3.833.550 $ | +3.833.550 $ | 1 | |||||||||||||
| ARDELYX, INC. | ARDX | → 0 | Neutral | 3.502.904 $ | +411.279 $ | +13,3 % | 1 | 3.091.625 $ | +3.091.625 $ | 1 | |||||||||
| BridgeBio Pharma, Inc. | BBIO | → 0 | Neutral | 3.286.970 $ | +3.286.970 $ | 1 | |||||||||||||
| Intellia Therapeutics, Inc. | NTLA | → 0 | Neutral | 3.133.195 $ | +3.133.195 $ | 1 | |||||||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Neutral | 3.124.032 $ | +3.124.032 $ | 1 | |||||||||||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 3.079.200 $ | +3.079.200 $ | 1 | |||||||||||||
| Certara, Inc. | CERT | → 0 | Neutral | 2.031.278 $ | -786.226 $ | -27,9 % | 1 | 2.817.504 $ | +2.817.504 $ | 1 | |||||||||
| BioNTech SE | BNTX | → 0 | Neutral | 2.734.930 $ | -1.254.501 $ | -31,4 % | 1 | ||||||||||||
| Arcellx, Inc. | ACLX | → 0 | 2.627.939 $ | +981.689 $ | +59,6 % | 1 | |||||||||||||
| CG Oncology, Inc. | CGON | → 0 | Schwach | 2.160.659 $ | +2.160.659 $ | 1 | |||||||||||||
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Neutral | 1.881.000 $ | +1.881.000 $ | 1 | |||||||||||||
| 460.970.513 $ | +58.444.286 $ | +27,3 % | 40 | 423.489.426 $ | +247.231 $ | -9,9 % | 42 | 438.714.301 $ | +77.181.238 $ | +25,9 % | 36 | 403.318.033 $ | +108.147.156 $ | +27,3 % | 41 | ||||
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score und die daraus abgeleiteten Signale sind das Ergebnis eines
regelbasierten Scoring-Modells aus öffentlich verfügbaren Daten (SEC-Filings,
Fundamentaldaten, Kursdaten). Sie richten sich an ein breites Publikum und
berücksichtigen keine persönlichen Verhältnisse, Anlageziele oder Risikobereitschaften.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Ersteller: Verantwortlich für Erstellung und Verbreitung ist der Betreiber dieser Website (siehe Impressum). Die Einstufung wird arbeitstäglich automatisiert neu berechnet.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in besprochenen Werten halten. Methodik: Methodik und Datenquellen.
Keine Anlageberatung, keine individuelle Empfehlung.
Der Glück Conviction Score ist das Ergebnis eines regelbasierten Scoring-Modells aus öffentlich
verfügbaren Daten. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.